Biotech · Private company · Boston, MA, US
Glial Therapeutics, LLC
Track this companyFree. Adds Glial Therapeutics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Targeting aVb8 integrin to restore astrocyte-microglia crosstalk to treat Alzheimer's diseaseFiscal year 2026 · $232.2KNIH RePORTER 5R41AG092194-02 · fetched Nov 12, 2026
- Targeting aVb8 integrin to restore astrocyte-microglia crosstalk to treat Alzheimer's diseaseFiscal year 2025 · $254.9KNIH RePORTER 1R41AG092194-01A1 · fetched Nov 12, 2026